Is TRNX a buy? - Seeking Alpha

Quote & Headlines Market Currents StockTalk

Today 5d 1m 3m 1y 5y 10y

52wk high:

52wk low:

EPS:

PE:

Div Rate:

Yield:

Market Cap:

Volume:

129 people get TRNX articles and Market Currents by email alert.

Get email alerts on TRNX »

HEADLINES:

Tornier Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Over-Allotment Option

Business Wire (May 15, 2013)
Tornier Announces Pricing of Public Offering of Ordinary Shares

Business Wire (May 9, 2013)
Tornier's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8
Tornier Announces Follow-on Offering of Ordinary Shares

Business Wire (May 7, 2013)
Tornier Reports First Quarter 2013 Results

Business Wire (May 7, 2013)
Tornier to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire (Apr 26, 2013)
Maybe More Than Meets The Eye To Stryker's Numbers
Stephen Simpson • Thu, Apr 25
Tornier Announces First Quarter 2013 Conference Call

Business Wire (Apr 3, 2013)
Tornier's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 21
Tornier Names David H. Mowry President and Chief Executive Officer

Business Wire (Feb 21, 2013)
Tornier Reports Fourth Quarter and Fiscal Year 2012 Results and Provides 2013 Outlook

Business Wire (Feb 21, 2013)
3 High-Growth European Stocks With Encouraging Inventory Trends
Kapitall • Tue, Feb 12
Tornier to Present at the 2013 RBC Capital Markets Global Healthcare Conference

Business Wire (Feb 11, 2013)
Tornier Announces 2012 Fourth Quarter and Full Year Conference Call

Business Wire (Jan 22, 2013)
Tornier Reiterates Fourth Quarter and Full Year 2012 Revenue Guidance

Business Wire (Jan 7, 2013)
Tornier to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire (Dec 18, 2012)
Tornier to Present at the 24th Annual Piper Jaffray Healthcare Conference

Business Wire (Nov 15, 2012)
Tornier Appoints David H. Mowry as Interim President and Chief Executive Officer

Business Wire (Nov 12, 2012)
Tornier Reports Third Quarter 2012 Financial Results

Business Wire (Nov 5, 2012)
Tornier to Present at the Credit Suisse 2012 Healthcare Conference

Business Wire (Nov 1, 2012)

To learn more about Seeking Alpha Pro, click here.

Tornier's Acquisition Of OrthoHelix Results In Further Dilution
The Value Investor • Mon, Aug 27, 2012
Post-Hype Sleepers: A Look At An Overlooked Stock Class And Tornier
Daniel Shvartsman • Tue, Jul 24, 2012 • 3 Comments
Tornier Prices IPO at Low End of Range
SA Editor Mohit Manghnani • Sun, Feb 6, 2011

Maybe More Than Meets The Eye To Stryker's Numbers
Stephen Simpson • Thu, Apr 25
3 High-Growth European Stocks With Encouraging Inventory Trends
Kapitall • Tue, Feb 12
10 High-Growth Healthcare Stocks With Strong Inventory Trends
Kapitall • Tue, Sep 18, 2012
7 Low-Debt Small Cap Stocks Slated For Growth
ZetaKap • Sun, Sep 16, 2012 • 2 Comments
Top Medtech Analyst Points To Post-Obamacare Opportunities
Life Sciences Report • Thu, Sep 6, 2012
10 Medical Device Stocks Hedge Funds Are Buying Up
Kapitall • Fri, Aug 17, 2012 • 4 Comments
Post-Hype Sleeper: Checking Out Epocrates' Oath To Customers, Investors
Daniel Shvartsman • Tue, Jul 31, 2012 • 1 Comment
5 High-Growth Medical Device Stocks With Strong Inventory Trends
Kapitall • Mon, Jul 30, 2012
12 High-Growth Healthcare Stocks With Strong Inventory Trends
Kapitall • Thu, Apr 26, 2012
12 Outperforming Healthcare Stocks With Encouraging Inventory Trends
Kapitall • Fri, Mar 23, 2012
Analyzing European Stocks That May Buck The Trend
MyPlanIQ • Wed, Feb 29, 2012 • 1 Comment
3 European Hedge Fund Stock Picks With Encouraging Receivable Trends
Kapitall • Thu, Feb 23, 2012
4 European Stocks With Significant Short Covering
Kapitall • Thu, Feb 16, 2012
Integra LifeSciences Sputters At Year End, But Is Still Undervalued
Stephen Simpson • Fri, Jan 6, 2012 • 2 Comments
How And When To Know Which IPOs To Invest In
Brian Nichols • Sun, Dec 18, 2011 • 5 Comments
20 Oversold Stocks Deeply Undervalued By Target Price
Kapitall • Fri, Nov 11, 2011
18 Healthcare Stocks Undervalued By Target Price
Kapitall • Wed, Nov 9, 2011
Integra Hitting That Same Ortho Wall
Stephen Simpson • Wed, Nov 2, 2011 • 2 Comments
Tudou: Last Week's Lone IPO Stumbles In Debut
Renaissance Capital IPO Research • Mon, Aug 22, 2011 • 2 Comments
Biotech IPO Class of 2011 Takes Drubbing
The Burrill Report • Sun, Aug 14, 2011

Tornier's CEO Discusses Q1 2013 Results - Earnings Call Transcript
Wed, May 8
Tornier's CEO Discusses Q4 2012 Results - Earnings Call Transcript
Thu, Feb 21

Tornier Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Underwriters’ Over-Allotment Option

Business Wire (May 15, 2013)
Tornier Announces Pricing of Public Offering of Ordinary Shares

Business Wire (May 9, 2013)
Tornier Announces Follow-on Offering of Ordinary Shares

Business Wire (May 7, 2013)
Tornier Reports First Quarter 2013 Results

Business Wire (May 7, 2013)
Tornier to Present at the Bank of America Merrill Lynch 2013 Health Care Conference

Business Wire (Apr 26, 2013)
Tornier Announces First Quarter 2013 Conference Call

Business Wire (Apr 3, 2013)
Tornier Names David H. Mowry President and Chief Executive Officer

Business Wire (Feb 21, 2013)
Tornier Reports Fourth Quarter and Fiscal Year 2012 Results and Provides 2013 Outlook

Business Wire (Feb 21, 2013)
Tornier to Present at the 2013 RBC Capital Markets Global Healthcare Conference

Business Wire (Feb 11, 2013)
Tornier Announces 2012 Fourth Quarter and Full Year Conference Call

Business Wire (Jan 22, 2013)
Tornier Reiterates Fourth Quarter and Full Year 2012 Revenue Guidance

Business Wire (Jan 7, 2013)
Tornier to Present at the 31st Annual J.P. Morgan Healthcare Conference

Business Wire (Dec 18, 2012)
Tornier to Present at the 24th Annual Piper Jaffray Healthcare Conference

Business Wire (Nov 15, 2012)
Tornier Appoints David H. Mowry as Interim President and Chief Executive Officer

Business Wire (Nov 12, 2012)
Tornier Reports Third Quarter 2012 Financial Results

Business Wire (Nov 5, 2012)
Tornier to Present at the Credit Suisse 2012 Healthcare Conference

Business Wire (Nov 1, 2012)
Tornier Announces Third Quarter 2012 Conference Call

Business Wire (Oct 17, 2012)
Tornier to Acquire OrthoHelix Surgical Designs

Business Wire (Aug 24, 2012)
Tornier Reports Second Quarter 2012 Financial Results

Business Wire (Aug 7, 2012)
Tornier Appoints New Chief Financial Officer

Business Wire (Jul 18, 2012)

TRNX vs. ETF Alternatives

Company Description

Currently, there's no company description for TRNX.

Sector: Healthcare

Industry: Medical Instruments & Supplies

Country: United States

All
| Earnings
| Dividends
| M&A
| On the move

Friday, May 10, 10:45 AM Tornier (TRNX -0.7%) prices its 7M share public offering at $16.15, just a 1.5% discount to yeserday's closing price. Of the 7M shares sold, 4.5M were by TRNX, while 2.5M were sold by existing shareholders. The company expects to use the net proceeds for working capital, repayment and refinancing of debt and general corporate purposes, including clinical and product development, capital expenditures and the acquisition of technologies, products or businesses. Comment! [Healthcare, Global & FX]
Tuesday, May 7, 8:03 PM Tornier (TRNX): Q1 EPS of -$0.17 misses by $0.07. Revenue of $82.7M beats by $1.1M. (PR) Comment! [Earnings, Breaking News, Healthcare]
Monday, November 12, 2012, 4:37 PM Tornier (TRNX) announces the appointment of David Mowry as Interim President and CEO, effective immediately. Mr. Mowry, who joined TRNX in July 2011 as COO, succeeds retiring CEO and Executive Director Douglas Kohrs. Also effective immediately, Non-Executive Director, Kevin O’Boyle has been named Interim Vice Chairman to serve as a liaison between Mowry and the board. Mowry joined Tornier N.V. in July 2011 as Chief Operating Officer. Comment! [Healthcare]
Friday, August 24, 2012, 2:04 PM In an effort to expand its sales to foot and ankle surgeons, medical-device maker Tornier (TRNX +1.2%) acquires OrthoHelix Surgical Designs in a $135M cash and stock deal. Wells Fargo sees the match up as "smart" because it will increase the proportion of sales from the faster-growing extremities business versus its large-joint business. Comment! [Healthcare, M&A]
Wednesday, February 15, 2012, 11:06 AM Craig-Hallum initiates Tornier (TRNX +1.3%) with a Strong Buy rating and $26 price target, helping stir up above-average trading volume on the global medical device company. Comment! [On the Move]
Monday, January 9, 2012, 1:11 PM Tornier (TRNX +4.3%) jumps after announcing preliminary Q4 sales of $69M (+12.7% Y/Y), beating Street estimates by $1.9M. The Dutch medical device maker's growth was driven by a 17.5% Y/Y increase in sales of prosthetics for extremities. Comment! [Healthcare, Earnings, On the Move]
Tuesday, November 1, 2011, 10:15 AM Medical device manufacturer Tornier (TRNX -8%) trades down after JP Morgan cuts the stock to Neutral on valuation. The firm says that although it still believes in the company's long-term strategy, it prefers to move to the sidelines to see how the next few quarters "shake out." 1 Comment [On the Move, Healthcare]

TRNX Tornier BV

TRNX

Tornier BV